Tenderwize
Retour à la recherche

Open House Drug Discount Agreement Posaconazole

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 219 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Posaconazol, ATC J02AC04

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

30 / 100

Facteurs de risque

No contract value or volume is disclosed. Potential revenue is unknown.

The open-house agreement automatically suspends if a competitive discount contract for the same substance comes into ef...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for Posaconazole (ATC J02AC04) with AOK Bayern.
  • Pharmaceutical companies must supply Posaconazole products and adhere to the discount terms set in the contract.
Afficher le résumé complet

This is an open-house model (non-competitive) for non-exclusive drug discount agreements for Posaconazole (ATC J02AC04) by AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract period. The contract runs from 01.06.2025 to 31.05.2027. No estimated value is provided. Eligibility requires a signed self-declaration of reliability. Submission can be in paper form (2 copies) or electronically with a qualified electronic signature via the DTVP portal. The notice explicitly states this is not a public procurement procedure under EU procurement law.

Risques

No contract value or volume is disclosed. Potential revenue is unknown.

The open-house agreement automatically suspends if a competitive discount contract for the same substance comes into ef...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Must submit a signed self-declaration of reliability (downloaded from the procurement portal).
  • The signed contract and annex 'Specification of the contract drugs' must be submitted along with the self-declaration.

Critères d'attribution

Lot 1

No award criteria are specified as this is an open-house model with no competitive selection.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreement Posaconazole

Non-exclusive discount agreements for the active substance Posaconazole (ATC J02AC04). The contract is open to all interested pharmaceutical companies that meet the eligibility criteria. Contracts can be concluded at any time up to 05.04.2027, with earliest start 01.06.2025 and all contracts ending 31.05.2027.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria are specified as this is an open-house model with no competitive selection.

Date limite

Deadline Apr 05, 2027

Détails de la procédure

Date de publication
15 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
248660-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30